Anti-adenoviral effect of interferon-β and interferon-γ in serotypes that cause acute keratoconjunctivitis

Eiichi Uchio1, Hirotoshi Inoue, Aki Fuchigami

  • 1Department of Ophthalmology, Fukuoka University School of Medicine, Fukuoka,Japan. euchio@fukuoka-u.ac.jp

Abstract

Insights

Interferon-beta and interferon-gamma demonstrate in vitro anti-adenoviral activity against key serotypes. These findings suggest potential for treating adenoviral keratoconjunctivitis, pending further trials.

Area of Science:

  • Virology
  • Immunology
  • Ophthalmology

Background:

  • Interferons are established treatments for hepatitis B and C virus infections.
  • The efficacy of interferons against adenovirus, particularly in causing acute keratoconjunctivitis, remains largely unelucidated.
  • Previous studies indicated potential effectiveness of interferon-beta and interferon-gamma against adenovirus serotype 3.

Purpose of the Study:

  • To investigate the in vitro anti-adenoviral effects of interferon-beta and interferon-gamma.
  • To evaluate the efficacy of these interferons against adenovirus serotypes responsible for acute keratoconjunctivitis.
  • To determine the dose-dependent inhibitory effects and quantify the 50% effective concentration (EC50) for each interferon-adenovirus serotype combination.

Main Methods:

  • An experimental in vitro study was conducted using A549 cells.
  • Five adenovirus serotypes (AdV3, AdV4, AdV8, AdV19a, AdV37) and interferon-beta and interferon-gamma were utilized.
  • Adenoviral DNA was quantified using real-time polymerase chain reaction after 24-hour interferon pretreatment and 7-day adenovirus cultivation.

Main Results:

  • Interferon-beta exhibited a dose-dependent inhibitory effect across all tested adenovirus serotypes, with EC50 values ranging from 211 to 843 IU/mL.
  • Interferon-gamma also demonstrated a dose-dependent anti-adenoviral effect, with EC50 values ranging from 133 to 9130 IU/mL.
  • Interferon-gamma showed the strongest inhibition against AdV37, while AdV4 displayed the lowest sensitivity to interferon-gamma. Dose dependency was statistically significant for both interferons against several serotypes.

Conclusions:

  • Both interferon-beta and interferon-gamma possess significant in vitro anti-adenoviral activity.
  • These interferons show promise for the local treatment of adenoviral keratoconjunctivitis.
  • Further research, including animal model studies and clinical trials, is warranted to confirm therapeutic potential.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...